Average weight loss of ~21% at 72 weeks in adults with obesity if all patients stayed on treatment* with Wegovy® HD (~19% regardless of whether patients stayed on treatment**) in the STEP UP trial1 In the STEP UP trial, about one in three trial participants taking Wegovy® HD achieved 25%...
Hence then, the article about fda approves novo nordisk s new wegovy hd injection delivering the highest weight loss to date for a wegovy injection adding to its already expansive clinical profile was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( FDA approves Novo Nordisk's new Wegovy® HD injection, delivering the highest weight loss to date for a Wegovy® injection, adding to its already expansive clinical profile )
Also on site :
- ‘The Young and the Restless’ Legend Eileen Davidson Reveals How One ‘Topical’ Storyline Literally Saved Fans’ Lives (Exclusive)
- Think 2026: IBM Makes Digital Sovereignty Operational with General Availability of IBM Sovereign Core
- RVezy is Rewriting the Rules of RV Travel Protection, and the Rest of the Industry is Being Left Behind